Late Breaking Abstract - Risk of a severe exacerbation following higher reliever use: post-hoc analysis of SYGMA 1 in mild asthma

被引：1
|
作者：
O'Byrne, Paul [1 ,2 ]
Fitzgerald, J. Mark [3 ]
Bateman, Eric D. [4 ]
Barnes, Peter J. [5 ]
Zhong, Nanshan [6 ]
Keen, Christina [7 ]
Wang, Millie [8 ]
Lamarca, Rosa [9 ]
Puu, Margareta [7 ]
Reddel, Helen K. [10 ]
机构：
[1] St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON, Canada
[2] McMaster Univ, Michael G DeGroote Sch Med, Dept Med, Hamilton, ON, Canada
[3] Univ British Columbia, Inst Heart & Lung Hlth, Vancouver, BC, Canada
[4] Univ Cape Town, Div Pulmonol, Dept Med, Cape Town, South Africa
[5] Imperial Coll, Natl Heart & Lung Inst, Airway Dis Sect, London, England
[6] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China
[7] AstraZeneca, Gothenburg, Sweden
[8] AstraZeneca, Cambridge, England
[9] AstraZeneca, Barcelona, Spain
[10] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW, Australia
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.OA1680
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA1680
引用
收藏
页数：3
相关论文
共 19 条
  • [1] Number needed to treat (NNT) to have an additional patient free from a severe or moderate/severe exacerbation: post-hoc analysis of SYGMA 1 in mild asthma
    Fitzgerald, Mark
    O'Byrne, Paul M.
    Bateman, Eric D.
    Barnes, Peter J.
    Zhong, Nanshan
    Alagappan, Vijay
    Whelan, Glenn
    Lamarca, Rosa
    Puu, Margareta
    Reddel, Helen K.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [2] NUMBER NEEDED TO TREAT WITH AS-NEEDED BUDESONIDE/FORMOTEROL OR BUDESONIDE MAINTENANCE TO HAVE AN ADDITIONAL PATIENT FREE FROM A SEVERE OR MODERATE/SEVERE EXACERBATION: POST-HOC ANALYSIS OF SYGMA 1 IN MILD ASTHMA
    Reddel, H.
    O'Byrne, P.
    Bateman, D. E.
    Barnes, P.
    Zheng, J.
    Lamarca, R.
    Puu, M.
    Alagappan, V
    Fitzgerald, J.
    [J]. RESPIROLOGY, 2020, 25 : 106 - 106
  • [3] Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study
    O'Byrne, Paul M.
    FitzGerald, J. Mark
    Bateman, Eric D.
    Barnes, Peter J.
    Zheng, Jinping
    Gustafson, Per
    Lamarca, Rosa
    Puu, Margareta
    Keen, Christina
    Alagappan, Vijay K. T.
    Reddel, Helen K.
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (02): : 149 - 158
  • [4] Late Breaking Abstract - Reduction of COPD exacerbations with extrafine single inhaler triple therapy: post-hoc analysis by exacerbation treatment of the TRIBUTE study
    Fabbri, Leonardo
    Singh, Dave
    Valente, Ilaria
    Guasconi, Alessandro
    Prunier, Helene
    Georges, George
    Papi, Alberto
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [5] Late Breaking Abstract - Exploring technology preferences and reliever inhaler use in adults with asthma - survey results with behavioural segmentation analysis
    Bennett-Steele, Naomi
    Cumella, Andrew
    Francis, Anna
    Walker, Samantha
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [6] Late Breaking Abstract - Baseline characteristics impact on asthma exacerbation risk: individual patient trial data analysis
    Paggiaro, Pierluigi
    Price, David
    Roche, Nicolas
    Moreira, Sebastian
    Verma, Manish
    Girotra, Shalini
    Plank, Maximilian
    Oosterholt, Sean
    Della Pasqua, Oscar
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [7] Late Breaking Abstract - Extrafine triple therapy reduces exacerbations in GOLD B COPD patients: post-hoc analysis of TRILOGY and TRINITY
    Singh, Dave
    Fabbri, Leonardo
    Papi, Alberto
    Vezzoli, Stefano
    Muraro, Annamaria
    Petruzzelli, Stefano
    Curi, Mario S.
    Vestbo, Jorgen
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [8] The use of β2-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysis
    Mitesh Patel
    Janine Pilcher
    Robert J Hancox
    Davitt Sheahan
    Alison Pritchard
    Irene Braithwaite
    Dominick Shaw
    Peter Black
    Mark Weatherall
    Richard Beasley
    [J]. npj Primary Care Respiratory Medicine, 25
  • [9] The use of β2-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysis
    Patel, Mitesh
    Pilcher, Janine
    Hancox, Robert J.
    Sheahan, Davitt
    Pritchard, Alison
    Braithwaite, Irene
    Shaw, Dominick
    Black, Peter
    Weatherall, Mark
    Beasley, Richard
    [J]. NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2015, 25
  • [10] LATE-BREAKING ABSTRACT: Association of incident pneumonia and exacerbations with extrafine beclometasone dipropionate/formoterol (BDP/FF) in severe COPD patients: A post-hoc analysis of FORWARD study
    Corradi, Massimo
    Spinola, Monica
    Guasconi, Alessandro
    Cohuet, Geraldine
    Montagna, Isabella
    Bizzi, Andrea
    Petruzzelli, Stefano
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
12